Latest news
Narrow-Moat Steris' Recurring Revenue and Margin Improvement Create Opportunistic Outlook - MorningstarMorningstar · Fri, 07 Aug 2026 16:37:38 GMTU Q2 Deep Dive: AI-Powered Platform Drives Revenue, Margin Expansion, and Strategic Partnerships - TradingViewTradingView · Fri, 07 Aug 2026 05:46:00 GMTCytoSorbents plans early-2027 FDA filing for blood-thinner device - Stock TitanStock Titan · Thu, 06 Aug 2026 20:25:00 GMTPrivate Label Power Play: Moving From Margin to Market Clout - Hardware RetailingHardware Retailing · Sat, 01 Aug 2026 15:51:54 GMTRethinking Business Margin Improvement - DeloitteDeloitte · Mon, 27 Jul 2026 18:01:28 GMT